Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae

Vaccine

Volumn 26, Issue 6, 2008, Pages 743-752

  Tobias, Joshua ^a   Lebens, Michael ^a   Bölin, Ingrid ^a   Wiklund, Gudrun ^a   Svennerholm, Ann Mari ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

CFA I; ETEC; Vibrio cholerae

Indexed keywords

BACTERIAL ANTIGEN; ESCHERICHIA COLI COLONIZATION FACTOR ANTIGEN 1; ESCHERICHIA COLI ENTEROTOXIN; ESCHERICHIA COLI VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 2 RECEPTOR ALPHA; ISOPROPYL THIOGALACTOSIDE; PLASMID VECTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CONTROLLED STUDY; ELECTRON MICROSCOPY; ESCHERICHIA COLI; EXPRESSION VECTOR; FEMALE; FIMBRIA; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; VIBRIO CHOLERAE; WILD TYPE;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FIMBRIAE PROTEINS; FIMBRIAE, BACTERIAL; FORMALDEHYDE; IMMUNIZATION; IMMUNIZATION SCHEDULE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MICE; MICE, INBRED BALB C; OPERON; PLASMIDS; PROTEIN ENGINEERING; RECOMBINANT PROTEINS; VACCINES, SYNTHETIC; VIBRIO CHOLERAE;

EID: 38349049215     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.12.009     Document Type: Article

References (43)

1. Black R.E. Epidemiology of travelers' diarrhea and relative importance of various pathogens. Rev Infect Dis 12S 1 (1990) S73-S79
2. Qadri F., Svennerholm A.-M., Faruque A.S.G., and Sack R.B. Enterotoxigenic Escherichia coli (ETEC): epidemiology, microbiology, and clinical features in developing countries. Clin Microb Rev 18 (2005) 465-483
3. Serichantalergs O., Nirdnoy W., Cravioto A., LeBron C., Wolf M., Svennerholm A.-M., et al. Coli surface antigens associated with enterotoxigenic Escherichia coli strains isolated from persons with traveler's diarrhea in Asia. J Clin Microbiol 35 (1997) 1639-1641
4. Kosek M., Bern C., and Guerrant R.L. The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bull WHO 81 (2003) 197-204
5. Gaastra W., and Svennerholm A.-M. Colonization factors of human enterotoxigenic Escherichia coli (ETEC). Trends Microbiol 4 (1996) 444-452
6. Jansson L., Tobias J., Lebens M., Svennerholm A.-M., and Teneberg S. Glycosphingolipid binding specificity of colonization factor antigen I from enterotoxigenic Escherichia coli. Infect Immun 74 (2006) 3488-3497
7. Evans D.G., Silver R.P., Evans Jr. D.J., Chase D.J., and Gorbach S.L. Plasmid-controlled colonization factor associated with virulence in E. coli enterotoxigenic for humans. Infect Immun 18 (1975) 330-337
8. Binsztein N., Jouve M.J., Viboud G.I., Moral L.L., Rivas M., Orskov I., et al. Colonization factors of enterotoxigenic Escherichia coli isolated from children with diarrhea in Argentina. J Clin Microbiol 29 (1991) 1893-1898
9. Qadri F., Das S.K., Faruque A.S., Fuchs G.J., Albert M.J., Sack R.B., et al. Prevalence of toxin types and colonization factors in enterotoxigenic Escherichia coli isolated during a 2-year period from diarrheal patients in Bangladesh. J Clin Microbiol 38 (2000) 27-31
10. Shaheen H.I., Khalil S.B., Rao M.R., Abu Elyazeed R., Wierzba T.F., Peruski Jr. L.F., et al. Phenotypic profiles of enterotoxigenic Escherichia coli associated with early childhood diarrhea in rural Egypt. J Clin Microbiol 42 (2004) 5588-5595
11. Bühler T., Hoschützky H., and Jann K. Analysis of colonization factor antigen I, an adhesin of enterotoxigenic Escherichia coli O78:H11: fimbrial morphology and location of the receptor-binding site. Infect Immun 59 (1991) 3876-3882
12. Rudin A., and Svennerholm A.-M. Colonization factor antigens (CFAs) of enterotoxigenic Escherichia coli can prime and boost immune responses against heterologous CFAs. Microb Pathog 16 (1994) 131-139
13. Sakellaris H., Munson G.P., and Scott J.R. A conserved residue in the tip proteins of CS1 and CFA/I pili of enterotoxigenic Escherichia coli that is essential for adherence. Proc Natl Acad Sci USA 96 (1999) 12828-12832
14. Anantha R.P., McVeigh A.L., Lee L.H., Agnew M.K., Cassels F.J., Scott D.A., et al. Evolutionary and functional relationships of colonization factor antigen I and other class 5 adhesive fimbriae of enterotoxigenic Escherichia coli. Infect Immun 72 (2004) 7190-7201
15. Ahren C.M., and Svennerholm A.-M. Experimental enterotoxin-induced Escherichia coli diarrhea and protection induced by previous infection with bacteria of the same adhesin or enterotoxin type. Infect Immun 50 (1985) 255-261
16. Levine M.M., Giron J.A., and Noriega F. Fimbrial vaccines. In: Klemm P. (Ed). Fimbriae: adhesion, biogenics, genetics and vaccines (1994), CRC Press, Boca Raton, FL 255-270
17. Svennerholm A.-M., Holmgren J., and Sack D.A. Development of oral vaccines against enterotoxigenic Escherichia coli diarrhea. Vaccine 7 (1989) 196-198
18. Svennerholm A.-M., Åhren C., and Jertborn M. Oral inactivated vaccines against enterotoxigenic Escherichia coli. In: Levine M.M., Woodrow G.C., Kaper J.B., and Gabon G.S. (Eds). New generation vaccines. 2nd ed. (1997), Marcel Dekker, New York 865-874
19. Svennerholm A.-M., and Savarino S.J. Oral inactivated whole cell B subunit combination vaccine against enterotoxigenic Escherichia coli. In: Levine M.M., Kaper J.B., Rappuoli R., Liu M.A., and Good M.F. (Eds). New generation vaccines. 3rd ed. (2004), Marcel Dekker, New York 737-750
20. Svennerholm A.-M., and Steele D. Progress in enteric vaccine development. Best Pract Res Clin Gastroenterol 18 (2004) 421-445
21. Evans D.G., Evans Jr. D.J., Clegg S., and Pauley J.A. Purification and characterization of the CFA/I antigen of enterotoxigenic Escherichia coli. Infect Immun 25 (1979) 738-748
22. Lebens M., Johansson S., Osek J., Lindblad M., and Holmgren J. Large-scale production of Vibrio cholerae toxin B subunit for use in oral vaccines. Biotechnology (NY) 11 (1993) 1574-1578
23. Stacey K.A., and Simon E. Improved method for the isolation of thymine-requiring mutants of Escherichia coli. J Bacteriol 99 (1965) 554-555
24. Sambrook J., and Russell D.W. Molecular cloning. A laboratory manual. 3rd ed. (2001), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York
25. Frisk A., Lebens M., Johansson C., Ahmed H., Svensson L., Ahlman K., et al. The role of different protein components from the Haemophilus ducreyi cytolethal distending toxin in the generation of cell toxicity. Microb Pathog 30 (2001) 313-324
26. Sadeghi H., Bregenholt S., Wegmann D., Petersen J.S., Holmgren J., and Lebens M. Genetic fusion of human insulin B-chain to the B-subunit of cholera toxin enhances in vitro antigen presentation and induction of bystander suppression in vivo. Immunology 106 (2002) 237-245
27. Lopez-Vidal Y., Klemm P., and Svennerholm A.-M. Monoclonal antibodies against different epitopes on colonization factor antigen I of enterotoxin-producing Escherichia coli. J Clin Microbiol 26 (1988) 1967-1972
28. Viboud G.I., Binsztein N., and Svennerholm A.-M. Characterization of monoclonal antibodies against putative colonization factors of enterotoxigenic Escherichia coli and their use in an epidemiological study. J Clin Microbiol 31 (1993) 558-564
29. Raghavan S., Svennerholm A.-M., and Holmgren J. Effects of oral vaccination and immunomodulation by cholera toxin on experimental Helicobacter pylori infection, reinfection, and gastritis. Infect Immun 70 (2002) 4621-4627
30. Butterton J.R., Boyko S.A., and Calderwood S.B. Use of the Vibrio cholerae irgA gene as a locus for insertion and expression of heterologous antigens in cholera vaccine strains. Vaccine 11 (1993) 1327-1335
31. Butterton J.R., Ryan E.T., Acheson D.W.K., and Calderwood S.B. Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains. Infect Immun 65 (1997) 2127-2135
32. Favre D., Lüdi S., Stoffel M., Frey J., Horn M.P., Dietrich G., et al. Expression of enterotoxigenic Escherichia coli colonization factors in Vibrio cholerae. Vaccine 24 (2006) 4354-4368
33. Holmgren J., Czerkinsky C., Lycke N., and Svennerholm A.-M. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant. Am J Trop Med Hyg 50 (1994) 42-54
34. Holmgren J., Svennerholm A.-M., Jertborn M., Clemens J., Sack D.A., Salenstedt R., et al. An oral B subunit: whole cell vaccine against cholera. Vaccine 10 (1992) 911-914
35. Clemens J.D., Sack D.A., Harris J.R., Chakraborty J., Neogy P.K., Stanton B., et al. Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial. J Infect Dis 158 (1988) 372-377
36. Peltola H., Siitonen A., Kyronseppa H., Simula I., Mattila L., Oksanen P., et al. Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine. Lancet 338 (1991) 1285-1289
37. Jertborn M., Svennerholm A.-M., and Holmgren J. Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease. J Clin Microbiol 24 (1986) 203-209
38. Kotton C.N., and Hohmann E.L. Enteric pathogens as vaccine vectors for foreign antigen delivery. Infect Immun 72 (2004) 5535-5547
39. Barry E.M., Altboum Z., Losonsky G., and Levine M.M. Immune responses elicited against multiple enterotoxigenic Escherichia coli fimbriae and mutant LT expressed in attenuated Shigella vaccine strains. Vaccine 21 (2003) 333-340
40. Koprowski II H., Levine M., Anderson R.J., Losonsky G., Pizza M., and Barry F.M. Attenuated Shigella flexneri 2a vaccine strain CVD1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli. Infect Immun 68 (2000) 4884-4892
41. Kerneis S., Caliot E., Stubbe H., Bogdanova A., Kraehenbuhl J., and Pringault E. Molecular studies of the intestinal mucosal barrier physiopathology using cocultures of epithelial and immune cells: a technical update. Microbes Infect 2 (2000) 1119-1124
42. Qadri F., Ahmed T., Ahmed F., Begum Y.A., Sack D.A., and Svennerholm A.-M. Reduced doses of oral killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine is safe and immunogenic in Bangladeshi infants 6-17 months of age: dosing studies in different age groups. Vaccine 24 (2006) 1726-1733
43. Qadri F., Khan A.I., Abu Syed G., Faruque A.S.G., Begum Y.A., Chowdhury F., et al. Enterotoxigenic Escherichia coli together with V. cholerae O1 was a major cause of acute watery diarrhea during the epidemic caused by flooding in Dhaka, Bangladesh during the summer of 2004. Emerg Infect Dis 11 (2005) 1104-1107